Loading…
DBV Technologies S.A. is projected to rise to $15.50 by 2027, a +15% move from its current price of $13.50. DBVT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $13.15 | $13.50 | $13.85 | -0.01% |
| Aug 3 | $13.01 | $13.50 | $14.00 | -0.02% |
| Aug 4 | $12.91 | $13.50 | $14.11 | -0.03% |
| Aug 5 | $12.81 | $13.49 | $14.21 | -0.04% |
| Aug 6 | $12.74 | $13.49 | $14.30 | -0.05% |
| Aug 7 | $12.66 | $13.49 | $14.37 | -0.06% |
| Aug 8 | $12.60 | $13.49 | $14.44 | -0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.60 | $13.49 | $14.44 | -0.07% |
| Week 2 | $12.24 | $13.48 | $14.85 | -0.15% |
| Week 3 | $11.97 | $13.47 | $15.16 | -0.22% |
| Week 4 | $11.74 | $13.46 | $15.43 | -0.29% |
| Week 5 | $11.54 | $13.45 | $15.67 | -0.37% |
| Week 6 | $11.37 | $13.44 | $15.89 | -0.44% |
| Week 7 | $11.21 | $13.43 | $16.09 | -0.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DBV Technologies S.A. is a clinical-stage biopharmaceutical company focused on epicutaneous immunotherapy products in France. Its product pipeline includes Viaskin Peanut, which has completed Phase 3 clinical trials for the treatment of peanut allergies, and Viaskin Milk, in Phase 1/2 for IgE-mediated or cow’s milk protein allergy and eosinophilic esophagitis.
The company also pursues earlier-stage research programs, including celiac disease, and develops the Viaskin technology platform. It collaborates with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for diagnosing non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A.
was incorporated in 2002 and is headquartered in Châtillon, France.
DBV Technologies S.A. (DBVT) is currently priced at $13.63 per share with a market cap of $806.66M. It ranks 2,587 by market cap. The current price sits at the start of a forecast horizon that envisions upside over time, with the 2026 range starting at $13.63 (min) and $13.63 (avg) up to $17.44 (max).
The longer-run outlook shows significant upside, with the 2030 average price at $23.69 and the 2050 average at $103.85, alongside rising max values. These projections imply meaningful long-term upside, with the 2030 max at $35.06 and the 2050 max at $198.44.
A major floor 19.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 28.5% above — a clean break opens room to run.
A major ceiling 64.0% above — clearing it would confirm fresh momentum.
Key DBVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DBVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.69 | Sell | $13.70 | Sell |
| MA 10 | $13.83 | Sell | $13.99 | Sell |
| MA 20 | $14.89 | Sell | $14.61 | Sell |
| MA 50 | $16.18 | Sell | $16.04 | Sell |
| MA 100 | $18.23 | Sell | $17.17 | Sell |
| MA 200 | $18.24 | Sell | $16.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.19 | Neutral |
| Stoch RSI (14) | 27.27 | Neutral |
| CCI (20) | -86.04 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -14.07 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.68 | Sell |
| Awesome (5,34) | -1.76 | Sell |
| Ultimate (7,14,28) | 37.78 | Neutral |
| Momentum (10) | -1.20 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 13.62 | Sell |
| ADX (14) | 25.31 | Sell |
| ATR (14) | 0.36 | Info |
The 30-day technical picture is Bearish, with RSI(14) at 30. The moving averages show SMA50 at $16.99 and SMA200 at $18.28, indicating resistance above the current price. The security has a nearby support at $13.63 and a resistance at $18.12.
Over the last 30 days, the price has traded within a range of $11.20 to $16.59, illustrating limited near-term upside.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.50 | $13.50 | $17.20 | 0% | Neutral | |
| $12.42 | $15.50 | $20.41 | +15% | Neutral | |
| $14.40 | $18.46 | $25.19 | +37% | Bullish | |
| $16.44 | $21.53 | $30.22 | +60% | Bullish | |
| $16.78 | $22.40 | $32.18 | +66% | Bullish | |
| $17.80 | $24.18 | $35.46 | +79% | Bullish | |
| $18.15 | $25.06 | $37.44 | +86% | Bullish | |
| $17.57 | $24.64 | $37.41 | +82% | Bullish | |
| $21.49 | $30.58 | $47.16 | +127% | Bullish | |
| $24.92 | $35.95 | $56.23 | +166% | Bullish | |
| $29.75 | $45.68 | $75.82 | +238% | Bullish | |
| $56.40 | $96.36 | $174.48 | +614% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $13.50 | $13.50 | $16.25 | +0.00% |
| September 2026 | $11.19 | $13.22 | $16.05 | -2.06% |
| October 2026 | $11.25 | $13.37 | $16.39 | +1.13% |
| November 2026 | $11.59 | $13.85 | $17.12 | +3.61% |
| December 2026 | $11.50 | $13.81 | $17.20 | -0.31% |
Click any year to see its month-by-month DBVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DBVT is projected to trade between $13.50 and $17.20, averaging $13.50 — a potential gain of 0% from today's $13.50. A consolidation phase looks the most probable path here.
DBV Technologies S.A.'s 2027 outlook centres on $15.50, within a $12.42 to $20.41 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. Price action looks broadly range-bound.
By 2028, DBVT could reach as high as $25.19, with a base case around $18.46 and support toward $14.40 — roughly +37% from $13.50. Buyers look set to stay in control over this stretch.
Expect DBVT to range from $16.44 to $30.22 through 2029. The $21.53 average target implies a +60% move from current prices. That is up +17% on the projected 2028 average. Momentum favours further upside here.
The DBVT price prediction for 2030 points to an average of $22.40 (low $16.78, high $32.18) — a potential gain of +66% on today's $13.50. Buyers look set to stay in control over this stretch.
In 2031, DBVT is projected to trade between $17.80 and $35.46, averaging $24.18 — a potential gain of +79% from today's $13.50. That is up +8% on the projected 2030 average. Momentum favours further upside here.
DBV Technologies S.A.'s 2032 outlook centres on $25.06, within a $18.15 to $37.44 range. That is up +4% on the projected 2031 average. That marks a +86% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DBVT could reach as high as $37.41, with a base case around $24.64 and support toward $17.57 — roughly +82% from $13.50. Momentum favours further upside here.
Expect DBVT to range from $21.49 to $47.16 through 2034. The $30.58 average target implies a +127% move from current prices. That is up +24% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DBVT price prediction for 2035 points to an average of $35.95 (low $24.92, high $56.23) — a potential gain of +166% on today's $13.50. Momentum favours further upside here.
In 2040, DBVT is projected to trade between $29.75 and $75.82, averaging $45.68 — a potential gain of +238% from today's $13.50. That is up +27% on the projected 2035 average. Buyers look set to stay in control over this stretch.
DBV Technologies S.A.'s 2050 outlook centres on $96.36, within a $56.40 to $174.48 range. That is up +111% on the projected 2040 average. That marks a +614% change versus current levels. Momentum favours further upside here.
Investing $1,000 in DBVT today (≈ 74.074074 DBVT) could be worth
$7,137.86
+$6,137.86 (+614%) by 2050 · US Dollar
Based on the average projected DBVT price of $96.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DBVTwould be worth at today's price.
$1,000 invested in DBVT on Jul 31, 2025 (≈ 117.50881 DBVT) would be worth
$1,586.37
+$586.37 (+58.6%) today · 1.59× · US Dollar
Based on a DBVT entry price of $8.51 vs. today's $13.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.63 | $990.46 | -1.0% |
| 1 month ago | $15.73 | $858.23 | -14.2% |
| 3 months ago | $19.87 | $679.42 | -32.1% |
| 6 months ago | $21.59 | $625.29 | -37.5% |
| 1 year ago | $8.51 | $1,586.37 | +58.6% |
| All time (5.0y) ago | $10.74 | $1,256.98 | +25.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DBVT forecast.
Our base-case forecast reaches $27.00 around 2034.
Implied market cap at $27.00: $1.6B
The multi-year forecast shows a path from a Neutral stance in 2026 (min $13.63, avg $13.63, max $17.44) to Bullish momentum in following years. By 2027 the average is $16.02 with a max of $21.50 and ROI of 17.5%; 2028 shows an average of $19.26 and max $26.92 with ROI 41.3%. The forecast continues higher, with 2029 average $22.44, 2030 average $23.69 (ROI 73.8%), and 2031–2033 values trending upward (2031 avg $25.32, ROI 85.8%; 2032 avg $25.82, ROI 89.4%; 2033 avg $25.72, ROI 88.7%).
In 2034 the average advances to $32.70 (ROI 139.9%), and 2035 to $38.42 (ROI 181.9%). The long-range view extends to 2040 average $48.72 (ROI 257.5%) and 2050 average $103.85 (ROI 661.9%), with a max of $198.44. These figures are estimates and reflect forward-looking projections that imply substantial upside potential, though they are not guarantees and carry inherent uncertainty.
Tap a question to reveal the answer.
In 2030 the forecast shows min $17.29, avg $23.69, max $35.06, ROI 73.8%, sentiment BULLISH.
The forecast displays a bullish trajectory from 2028 onward, with 2028 avg $19.26 and ROI 41.3%, 2029 avg $22.44 and ROI 64.7%, and 2030 avg $23.69 with ROI 73.8%, continuing to 2031–2050 with rising averages and ROI up to 661.9% in 2050.
Yes. The 2050 forecast lists a max of $198.44 and an average of $103.85, indicating potential to surpass $100 on the upside.
Current price is $13.63 and market cap is $806.66M.
The sentiment is BEARISH with RSI(14) at 30. The SMA50 is $16.99 and the SMA200 is $18.28. Support is at $13.63 and resistance at $18.12. The 30-day price range is $11.20 to $16.59.
DBV Technologies S.A. Community Discussion
0Share your DBV Technologies S.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.